OKE vs VYNE · P/E 15, rev $21.67B vs rev $501.0K
ONEOK Inc (OKE) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported OKE revenue for 2026-06-30 was $21.67B. Net income was $1.74B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
OKE currently screens at market cap $53.92B and trailing P/E 15.3. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the OKE and VYNE stock pages for the full models.
Not investment advice.